Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dombkowski

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Experimental Hematology|October 11, 2003
NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507Christian Koenecke, Juanita Shaffer, Stephen I Alexander, et al.
Biochimica Et Biophysica Acta|March 18, 2014
Altered leukotriene B4 metabolism in CYP4F18-deficient mice does not impact inflammation following renal ischemiaValeria Winslow, Rachel Vaivoda, Aleksandr Vasilyev, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2006
Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsivenessPaul P Szotek, Rafael Pieretti-Vanmarcke, Peter T Masiakos, et al.
The Journal of Experimental Medicine|June 2, 2005
Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool sizeSebastian Stier, Yon Ko, Randolf Forkert, et al.
Blood|October 24, 2002
Heterologous cells cooperate to augment stem cell migration, homing, and engraftmentGregor B Adams, Karissa T Chabner, Russell B Foxall, et al.
Cytokines, Cellular & Molecular Therapy|February 28, 2003
Fluctuating lymphocyte chimerism, tolerance and anti-tumor response in a patient with refractory lymphoma receiving nonmyeloablative conditioning and a haploidentical related allogeneic bone marrow transplantHan C Toh, Thomas R Spitzer, Frederic Preffer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2008
Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristicsPaul P Szotek, Henry L Chang, Kristen Brennand, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substanceKatia Meirelles, Leo Andrew Benedict, David Dombkowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2010
Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeuticsXiaolong Wei, David Dombkowski, Katia Meirelles, et al.
Experimental Hematology|July 5, 2003
Early host CD8 T-cell recovery and sensitized anti-donor interleukin-2-producing and cytotoxic T-cell responses associated with marrow graft rejection following nonmyeloablative allogeneic bone marrow transplantationAnnette B Kraus, Juanita Shaffer, Han Chong Toh, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Experimental Hematology|October 11, 2003
NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507Christian Koenecke, Juanita Shaffer, Stephen I Alexander, et al.
Biochimica Et Biophysica Acta|March 18, 2014
Altered leukotriene B4 metabolism in CYP4F18-deficient mice does not impact inflammation following renal ischemiaValeria Winslow, Rachel Vaivoda, Aleksandr Vasilyev, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2006
Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsivenessPaul P Szotek, Rafael Pieretti-Vanmarcke, Peter T Masiakos, et al.
The Journal of Experimental Medicine|June 2, 2005
Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool sizeSebastian Stier, Yon Ko, Randolf Forkert, et al.
Blood|October 24, 2002
Heterologous cells cooperate to augment stem cell migration, homing, and engraftmentGregor B Adams, Karissa T Chabner, Russell B Foxall, et al.
Cytokines, Cellular & Molecular Therapy|February 28, 2003
Fluctuating lymphocyte chimerism, tolerance and anti-tumor response in a patient with refractory lymphoma receiving nonmyeloablative conditioning and a haploidentical related allogeneic bone marrow transplantHan C Toh, Thomas R Spitzer, Frederic Preffer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2008
Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristicsPaul P Szotek, Henry L Chang, Kristen Brennand, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substanceKatia Meirelles, Leo Andrew Benedict, David Dombkowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2010
Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeuticsXiaolong Wei, David Dombkowski, Katia Meirelles, et al.
Experimental Hematology|July 5, 2003
Early host CD8 T-cell recovery and sensitized anti-donor interleukin-2-producing and cytotoxic T-cell responses associated with marrow graft rejection following nonmyeloablative allogeneic bone marrow transplantationAnnette B Kraus, Juanita Shaffer, Han Chong Toh, et al.
Pageof 3